Technological advances in high-throughput screening

American Journal of PharmacoGenomics

Volumn 4, Issue 4, 2004, Pages 263-276

  Liu, Bailing ^a   Li, Songjun ^a   Hu, Jie ^a  

^a CHENGDU INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; BETA LACTAMASE; GREEN FLUORESCENT PROTEIN; LUCIFERASE;

AFFINITY CHROMATOGRAPHY; ANISOTROPY; CELL FREE SYSTEM; DNA MICROARRAY; ENERGY TRANSFER; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGH THROUGHPUT SCREENING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SCINTILLATION; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE;

ANIMALS; CELL-FREE SYSTEM; CHROMATOGRAPHY, AFFINITY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE; GENE LIBRARY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

EID: 4344698841     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404040-00006     Document Type: Review

References (101)

1. Entzeroth M. Emerging trends in high-throughput screening. Curr Opin Pharm 2003; 3 (5): 522-9
2. Segall M. Smart high-throughput screening. Drug Discov Today 2003; 8 (4): 160-1
3. Barrie SE, Eno-Amooquaye E, Hardcastle A, et al. High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal Biochem 2003; 320 (1): 66-74
4. Bolger R. High-throughput screening: new frontiers for the 21st century. Drug Discov Today 1999; 4 (6): 251-3
5. Silverman L, Campbell R, Broach JR. New assay technologies for high-throughput screening. Curr Opin Chem Biol 1998: 2(3): 397-403
6. Rich RL, Myszka DG. Survey of the year 2001 commercial optical biosensor literature. Mol Recogn 2002; 15 (6): 352-76
7. Moore JM. NMR screening in drug discovery. Curr Opin Biotech 1999; 10 (1): 54-8
8. Hajduk PJ, Gerfin T, Boehlen JM, et al. High-throughput nuclear magnetic resonance-based screening. J Med Chem 1999; 42 (13): 2315-7
9. Lowe CR. Combinatorial approaches to affinity chromatography. Curr Opin Chem Biol 2001; 5 (3): 248-56
10. Fodor SP, Read JL, Pirrung MC, et al. Lightdirected, spatially addressable parallel chemical synthesis. Science 1991; 251 (4995): 767-73
11. Chee M, Yang R, Hubbell E, et al. Accessing genetic information with high-density DNA arrays. Science, 1996; 274 (25): 610-4
12. Gu CC, Rao DC, Stormo G, et al. Role of gene expression microarray analysis in finding complex disease genes. Genet Epidemiol 2002; 23 (1): 37-56
13. DeFilippis V, Raggo C, Moses A, et al. Functional genomics in virology and antiviral drug discovery. Trends Biotech 2003; 21 (10): 452-7
14. Geary TG, Thompson DP, Klein RD. Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic. Int J Parasitol 1999; 29 (1): 105-12
15. Ramm P. Imaging systems in assay screening. Drug Discov Today 1999; 4 (9): 401-10
16. Cook ND. Scintillation proximity assay: a versatile high-throughput screening technology. Drug Discov Today 1996; 1 (7): 287-94
17. Grepin C, Pernelle C. High-throughput screening. Drug Discov Today 2000; 5 (5): 212-4
18. Battersby BJ, Trau M. Novel miniaturized systems in high-throughput screening. Trends Biotech 2002; 20 (4): 167-73
19. Pope AJ, Haupts UM, Moore KJ. Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice. Drug Discov Today 1999; 4 (8): 350-62.
20. Burbaum JJ, Sigal NH. New technologies for high-throughput screening. Curr Opin Chem Biol 1997; 1 (1): 72-8
21. Allen M, Reeves J, Mello G. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors. J Biomol Screen 2000; 5 (2): 63-9
22. Parker GJ, Law TL, Lenoch FJ, et al. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand- binding and kinase/phosphatase assays. J Biomol Screen 2000; 5 (2): 77-88
23. Li Z, Mehdi S, Patel L, et al. An ultra-high throughput screening approach for an adenine transferase using fluorescence polarization. Drug Discov Today 2000; 5 (1): 31-8
24. Sportsman JR, Leytes L. Miniaturization of homogeneous assays using fluorescence polarization. Drug Discov Today 2000; 1 Suppl.: 27-32
25. Auer M, Moore KJ, Meyer-Almes FJ, et al. Fluorescence correlation spectroscopy: lead discovery by miniaturized HTS. Drug Discov Today 1998; 3 (10): 457-65
26. Sittampalam GS, Kahl SD, Janzen WP. High-throughput screening: advances in assay technologies. Curr Opin Chem Biol 1997; 1 (3): 384-91
27. Chen Y, Müller JD, So PTC, et al. The photon counting histogram in fluorescence fluctuation spectroscopy. Biophys J 1999; 77 (1): 553-67
28. Fries JR, Brand L, Eggeling C, et al. Quantitative identification of different single molecules by selective time-resolved confocal fluorescence spectroscopy. J Phys Chem A 1998; 102 (33): 6601-13
29. Hertzberg RP, Pope AJ. High-throughput screening: new technology for the 21st century. Curr Opin Chem Biol 2000; 4 (4): 445-51
30. Sundberg SA. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr Opin Biotech 2000; 11 (1): 47-53
31. Kunapuli P, Ransom R, Murphy KL, et al. Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. Anal Biochem 2003; 314 (1): 16-29
32. Puckett LG, Lewis JC, Bachas LG, et al. Development of an assay for beta-lactam hydrolysis using the pH-dependence of enhanced green fluorescent protein. Anal Biochem 2002; 309 (2): 224-31
33. Alam J, Cook JL. Reporter genes for monitoring gene expression in mammalian cells. New Comprehens Biochem 2003; 38 (3): 290-308
34. Rossi FMV, Blakely BT, Blau HM. Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation. Trends Cell Biol 2000; 10 (3): 119-22
35. Lee JC, Chang CF, Chi YH, et al. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells. J Virol Methods 2004; 116 (1): 27-33
36. Boute N. Jockers R, Issad T. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharm Sci 2002; 23 (8): 351-4
37. Deo SK, Daunert S. Green fluorescent protein mutant as label in homogeneous assays for biomolecules. Anal Biochem 2001; 289 (1): 52-9
38. Milligan G. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. Euro J Pharm Sci 2004; 21 (4): 397-405
39. González JE, Oades K, Leychkis Y, et al. Cell-based assays and instrumentation for screening ion-channel targets. Drug Discov. Today 1999; 4 (9): 431-9
40. Allenby G, Dodgson K, Harper P, et al. Automated high throughput screening of fluorescent imaging plate reader (FLIPR) assays using assay platform™ integrated with activity base for 'on the fly' compound reconfirmation. J Assoc Lab Auto 2001; 6 (5): 48-50
41. Cacace A, Banks M, Spicer T, et al. An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors. Drug Discov Today 2003; 8 (17): 785-92
42. Soga T, Matsumoto SI, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002; 1579 (2): 173-9
43. Whiteaker KL, Gopalakrishnan SM, Groebe D, et al. Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators. J Biomol Screen 2001; 6 (5): 305-12
44. 2+-permeable AMPA/kainate receptor activation in murine neocortical neurons. Neuroscience Lett 2003; 351 (3): 145-8
45. Service RF. Lining up proteins for NMR. Science 1997; 278 (7): 1015-6
46. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300 (16): 1140-2
47. Shuker SB, Hajduk PJ, Meadows RP, et al. Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996; 274 (29): 1531-4
48. Moore JM. NMR screening in drug discovery. Curr Opin Biotech 1999; 10 (1): 54-8
49. Gerhard U, Thomas S, Mortishire-Smith R. Accelerated metabolite identification by "Extraction-NMR". J Pharm Biomed Anal 2003; 32 (3): 531-8
50. 19F relaxation measurements for the study of fluorinated ligand-receptor interactions. J Magn Reson 2001; 153 (1): 32-47
51. Lepre CA. Library design for NMR-based screening. Drug Discov Today 2001; 6 (3): 133-40
52. Dalvit C, Flocco M, Knapp S, et al. High-throughput NMR-based screening with competition binding experiments. J Am Chem Soc 2002; 124 (26): 7702-9
53. Fejzo J, Lepre CA, Peng JW, et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol 1999; 6 (10): 755-69
54. Diercks T, Coles M, Kessler H. Applications of NMR in drug discovery. Curr Opin Chem Biol 2001; 5 (3): 285-91
55. Keifer PA. Flow NMR applications in combinatorial chemistry. Curr Opin Chem Biol 2003; 7 (3): 388-94
56. Bemis GW, Murcko MA. The properties of known drugs: 1. Molecular frameworks. J Med Chem 1996; 39 (15): 2887-93
57. Bemis GW, Murcko MA. The properties of known drugs: 2. Side chains. J Med Chem 1999; 42 (25): 5095-9
58. Teng SF, Sproule K, Hussain A, et al. A strategy for the generation of biomimetic ligands for affinity chromatography. Combinatorial synthesis and biological evaluation of an IgG binding ligand. J Mol Recogn 1999; 12 (1): 67-75
59. Lauer I, Bonnewitz B, Meunier A, et al. New approach for separating Bacillus subtilis metalloprotease and α-amylase by affinity chromatography and for purifying neutral protease by hydrophobic chromatography. J Chromatogr B 2000; 737 (2): 277-84
60. Moaddel R, Wainer IW. Immobilized nicotinic receptor stationary phases: going with the flow in high-throughput screening and pharmacological studies. J Pharm Biomed Anal 2003; 30 (6): 1715-24
61. Bertucci C, Bartolini M, Gotti R, et al. Drug affinity to immobilized target biopolymers by high-performance liquid chromatography and capillary electrophoresis. J Chromatogr B 2003; 797 (1-2): 111-29
62. Hage DS, Tweed SA. Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. J Chromatogr B 1997; 699 (2): 499-525
63. Huyer G, Kelly J, Moffat J, et al. Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases. Anal Biochem 1998; 258 (1): 19-30
64. Mislovicová D, Breier PG. Study of porous cellulose beads as an affinity adsorbent via quantitative measurements of interactions of lactate dehydrogenase with immobilized anthraquinone dyes. Enzyme Microb Technol 1988; 10 (9): 568-73
65. Bohácová V, Docolomanský P, Breier A, et al. Interaction of lactate dehydrogenase with anthraquinone dyes: characterization of ligands for dyeligand chromatography. J Chromatogr B 1998; 715 (1): 273-81
66. Winzor DJ, Sawyer WH. Quantitative characterization of ligand binding. New York: Wiley-Liss, 1995
67. Wainer IW. Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases. J Chromatogr A 1994; 666 (2): 221-34
68. Chan NWC, Lewis DF, Rosner PJ, et al. Frontal affinity chromatography-mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensor. Anal Biochem 2003; 319 (1): 1-12
69. Nedved ML, Habibi-Goudarzi S, Ganem B, et al. Characterization of benzodiazepine "combinatorial" chemical libraries by on-line immunoaffinity extraction, coupled column HPLC-ion spray mass spectrometry-tandem mass spectrometry. Anal Chem 1996; 68 (23): 4228-36
70. Evans DM, Williams KP, McGuinness B, et al. Affinity-based screening of combinatorial libraries using automated, serial-column chromatography, Nature Biotechnol 1996; 14 (4): 504-10
71. Cooper MA. Biosensor profiling of molecular interactions in pharmacology. Curr Opin Pharm 2003; 3 (5): 557-62
72. Luppa PB, Sokoll LJ, Chan DW. Immunosensors: principles and applications to clinical chemistry. Clin Chim Acta 2001; 314 (1): 1-26
73. Myszka DG. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr Opin Biotech 1997; 8 (1): 50-7
74. Robbio LL, Uboldi P, Marcovina S, et al. Epitope mapping analysis of apolipoprotein B-100 using a surface plasmon resonance-based biosensor. Biosensors Bioelectr 2001; 16 (11): 963-9
75. Lambeck PV. Integrated opto-chemical sensors. Sensor Actuator B 1992; 8(1): 103-16
76. Ehnebom J, Björquist P, Sigurdardottir O, et al. Characterization of the interaction of plasminogen activator inhibitor type 1 with vitronectin by surface plasmon resonance. Fibrinol Proteol 2000; 14 (1): 47-57
77. McDonnell JM. Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition. Curr Opin Chem Biol 2001; 5 (5): 572-7
78. Yang WP, Wu H, Barbas CF. Surface plasmon resonance based kinetic studies of zinc finger-DNA interactions. J Immunol Methods 1995; 183 (1): 175-82
79. Kambhampati D, Nielsen PE, Knoll W. Investigating the kinetics of DNA-DNA and PNA-DNA interactions using surface plasmon resonance-enhanced fluorescence spectroscopy. Biosensors Bioelectr 2001; 16 (11): 1109-18
80. Katsamba PS, Park S, Laird-Offringa IA. Kinetic studies of RNA-protein interactions using surface plasmon resonance. Methods 2002; 26 (2): 95-104
81. Simonian AL, Revzin A, Wild JR, et al. Characterization of oxidoreductase-redox polymer electrostatic film assembly on gold by surface plasmon resonance spectroscopy and fourier transform infrared-external reflection spectroscopy. Anal Chim Acta 2002; 466 (2): 201-12
82. Myszka DG, Rich RL. Implementing surface plasmon resonance biosensors in drug discovery. Pharm Sci Technol Today 2000; 3 (9): 310-7
83. Ciolkowski ML, Fang MM, Lund ME. A surface plasmon resonance method for detecting multiple modes of DNA-ligand interactions. J Pharm Biomed Anal 2000; 22 (6): 1037-45
84. Ahmad A, Ramakrishnan A, McLean MA, et al. Use of surface plasmon resonance biosensor technology as a possible alternative to detect differences in binding of enantiomeric drug compounds to immobilized albumins. Biosensors Bioelectr 2003; 18 (4): 399-404
85. Woodbury RG, Wendin C, Clendenning J, et al. Construction of biosensors using a gold-binding polypeptide and a miniature integrated surface plasmon resonance sensor. Biosensors Bioelectr 1998; 13 (10): 1117-26
86. Stemmler I, Brecht A, Gauglitz G. Compact surface plasmon resonance-transducers with spectral readout for biosensing applications. Sensors Actuator B 1999; 54 (1): 98-105
87. Alterman M, Sjöbom H, Säfsten P, et al. P1/P1 modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays. Euro J Pharm Sci 2001; 13 (2): 203-12
88. Boehm HJ, Boehringer M, Bur D, et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem 2000; 43 (14): 2664-74
89. Carrasco C, Rosu F, Gabelica V, et al. Tight binding of the antitumor drug ditercalinium to quadruplex DNA. ChemBioChem 2002; 3 (12): 1235-41
90. Markgren PO, Hämäläinen M, Danielson UH. Kinetic analysis of the interaction between HIV-1 protease and inhibitors using optical biosensor technology. Anal Biochem 2000; 279 (1): 71-8
91. Conzone SD, Pantano CG. Glass slides to DNA microarrays. Mater Today 2004; 7 (3): 20-6
92. van Berkum NL, Holstege FCP. DNA microarrays: raising the profile. Curr Opin Biotech 2001; 12 (1): 48-52
93. Khandurina J, Guttman A. Microchip-based high-throughput screening analysis of combinatorial libraries. Curr Opin Chem Biol 2002; 6 (3): 359-66
94. Meloni R, Khalfallah O, Biguet NF. DNA microarrays and pharmacogenomics. Pharm Res 2004; 49 (4): 303-8
95. Liu Z, Bochner BS, Sypek JP, et al. Gene expression profiles in human nasal polyp tissues studied by DNA microarray. J Allergy Clin Immunol 2004; 113 (2 Suppl. 1): S326
96. Marton MJ, DeRisi JL, Bennett HA, et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 1998; 4 (3): 1293-301
97. Venton DL, Woodbury CP. Screening combinatorial libraries. Chemometr Intelligent Lab Syst 1999; 48 (2): 131-50
98. Mitra R, Powdrill T, Hogan ME. High throughput drug screening by direct RNA profiling on DNA sensors. Anal Chim Acta 2002; 469 (1): 141-8
99. Fire A. RNA-triggered gene silencing. Trends Genet 1999; 15 (9): 358-63
100. Sharp P. A. RNA interference -2001. Genes Dev 2001; 15 (10): 485-90
101. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411 (10): 494-8